Adding AKT Inhibitor Shows Benefit in PTEN-Deficient Prostate Cancer

Adding AKT Inhibitor Shows Benefit in PTEN-Deficient Prostate Cancer

The addition of the AKT inhibitor capivasertib (Truqap) to abiraterone (Zytiga) and androgen deprivation therapy (ADT) improved radiographic progression-free survival (rPFS) in patients with PTEN-deficient metastatic hormone-sensitive prostate cancer in the phase III CAPItello-281 study presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium. In this exclusive MedPage Today video, Daniel J. George,…

Read More

Democrats push 25th Amendment on Trump after dismissing Biden calls

NEWYou can now listen to Fox News articles! Congressional Democrats want President Donald Trump ousted through extraordinary measures, despite previously dismissing similar calls targeting former President Joe Biden. More than 50 Democratic lawmakers have called on Trump’s Cabinet to effectively depose him using the 25th Amendment, arguing that the president is unfit to serve over…

Read More